Free Trial

RadNet (RDNT) Competitors

RadNet logo
$59.86 -1.02 (-1.68%)
Closing price 04:00 PM Eastern
Extended Trading
$59.66 -0.20 (-0.33%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RDNT vs. FMS, HIMS, OPCH, GH, SHC, VCYT, BTSG, LFST, SGRY, and CON

Should you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.

RadNet vs.

RadNet (NASDAQ:RDNT) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, community ranking, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations.

RadNet has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.

Fresenius Medical Care has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$1.62B2.74$3.04M-$0.07-855.02
Fresenius Medical Care$21.05B0.64$540.07M$1.2119.08

Fresenius Medical Care has a net margin of 3.43% compared to RadNet's net margin of -0.25%. Fresenius Medical Care's return on equity of 6.04% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.25% 4.29% 1.45%
Fresenius Medical Care 3.43%6.04%2.69%

77.9% of RadNet shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are owned by institutional investors. 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Fresenius Medical Care received 71 more outperform votes than RadNet when rated by MarketBeat users. However, 66.10% of users gave RadNet an outperform vote while only 54.66% of users gave Fresenius Medical Care an outperform vote.

CompanyUnderperformOutperform
RadNetOutperform Votes
351
66.10%
Underperform Votes
180
33.90%
Fresenius Medical CareOutperform Votes
422
54.66%
Underperform Votes
350
45.34%

In the previous week, RadNet had 7 more articles in the media than Fresenius Medical Care. MarketBeat recorded 7 mentions for RadNet and 0 mentions for Fresenius Medical Care. RadNet's average media sentiment score of 0.63 beat Fresenius Medical Care's score of 0.00 indicating that RadNet is being referred to more favorably in the media.

Company Overall Sentiment
RadNet Positive
Fresenius Medical Care Neutral

RadNet currently has a consensus target price of $79.75, suggesting a potential upside of 33.23%. Fresenius Medical Care has a consensus target price of $25.30, suggesting a potential upside of 9.57%. Given RadNet's stronger consensus rating and higher probable upside, analysts plainly believe RadNet is more favorable than Fresenius Medical Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Fresenius Medical Care
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

RadNet beats Fresenius Medical Care on 11 of the 19 factors compared between the two stocks.

Get RadNet News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RDNT vs. The Competition

MetricRadNetMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$4.43B$2.96B$5.36B$9.14B
Dividend YieldN/A16.03%5.13%4.04%
P/E Ratio-855.0215.3489.4717.33
Price / Sales2.74200.681,263.70136.49
Price / Cash20.65426.0143.7535.97
Price / Book5.084.925.324.80
Net Income$3.04M-$33.85M$122.60M$224.91M
7 Day Performance-12.97%1.54%0.69%1.77%
1 Month Performance-21.77%-4.33%1.55%2.22%
1 Year Performance64.95%10.49%27.25%20.67%

RadNet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RDNT
RadNet
4.2986 of 5 stars
$59.86
-1.7%
$79.75
+33.2%
+66.2%$4.43B$1.62B-855.0210,288Analyst Forecast
News Coverage
FMS
Fresenius Medical Care
3.4209 of 5 stars
$22.25
-1.1%
$25.30
+13.7%
+18.2%$13.06B$19.24B18.391,358
HIMS
Hims & Hers Health
3.3285 of 5 stars
$25.55
+0.6%
$25.13
-1.6%
+229.9%$5.58B$1.24B58.071,046Insider Trade
Short Interest ↑
Gap Down
OPCH
Option Care Health
4.7517 of 5 stars
$27.60
+15.0%
$29.71
+7.7%
-9.2%$4.70B$4.78B23.195,600Analyst Forecast
Short Interest ↓
Analyst Revision
Positive News
GH
Guardant Health
3.9692 of 5 stars
$37.59
+2.4%
$40.60
+8.0%
+58.4%$4.64B$692.26M-8.871,779Short Interest ↓
SHC
Sotera Health
4.038 of 5 stars
$12.98
-1.0%
$16.08
+23.9%
-16.6%$3.68B$1.12B51.923,000
VCYT
Veracyte
4.0778 of 5 stars
$42.52
+2.4%
$41.13
-3.3%
+54.4%$3.30B$425.33M-283.47790Positive News
BTSG
BrightSpring Health Services
2.1249 of 5 stars
$17.22
+0.3%
$18.65
+8.3%
N/A$3.00B$10.59B-66.2335,000Positive News
LFST
LifeStance Health Group
1.1608 of 5 stars
$7.69
-0.5%
$8.70
+13.1%
+16.5%$2.94B$1.21B-29.589,325Short Interest ↓
Positive News
SGRY
Surgery Partners
2.2487 of 5 stars
$20.81
+0.8%
$36.56
+75.7%
-36.9%$2.65B$2.99B-43.3512,200
CON
Concentra Group Holdings Parent
N/A$20.53
+4.1%
$28.50
+38.8%
N/A$2.61B$1.88B0.0011,000Lockup Expiration
News Coverage
Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:RDNT) was last updated on 1/17/2025 by MarketBeat.com Staff
From Our Partners